LUCENTIS
LUCENTIS
Approved
DIN Number
02425629
Drug Class
Human
Market Date
Sep 18, 2014
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02425629
AIG Number0152224001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
S01LA04 RANIBIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravitreal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RANIBIZUMABActive
Strength: 10 MG / ML
Monograph: RANIBIZUMAB